Effects of danazol, gonadotropin-releasing hormone agonist, and a combination of danazol and gonadotropin-releasing hormone agonist on experimental endometriosis.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  American Journal of Obstetrics and Gynecology

• Publication date

  1990-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9378(90)90650-VPMID 2122726
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Studies on GnRH agonist suppression of estrogen production in patients with endometriosis.

  1989cited by this paper
• Preliminary report on the use of danazol in the treatment of endometrial adenomatous hyperplasia

  1988cited by this paper
• Persistent ovarian cysts following administration of human menopausal and chorionic gonadotropins: an attenuated form of ovarian hyperstimulation syndrome.

  1988cited by this paper
• The inhibitory effects of danazol, danazol metabolites, gestrinone, and testosterone on the growth of human endometrial cells in vitro.

  1988cited by this paper
• Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial.

  1988cited by this paper
• One-month release injectable microcapsules of a luteinizing hormone-releasing hormone agonist (leuprolide acetate) for treating experimental endometriosis in rats.

  1988cited by this paper
• Analysis of danazol in serum using high-performance liquid chromatography.

  1987cited by this paper
• Clomiphene citrate induces pituitary GnRH receptors in ovariectomized rats: its possible role in induction of ovulation.

  1986cited by this paper
• Danazol binds to progesterone receptors and inhibits the growth of human endometrial cancer cells in vitro.

  1986cited by this paper
• Short‐term effects of danazol on endometrial histology

  1984cited by this paper
• Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women.

  1984cited by this paper
• Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis.

  1984cited by this paper
• The effect of a luteinizing hormone releasing hormone (LRH) agonist (Wy-40,972), levonorgestrel, danazol and ovariectomy on experimental endometriosis in the rat.

  1984cited by this paper
• Serum hormone and steroid hormone receptor levels during luteal-phase and long-term treatment with danazol.

  1983cited by this paper
• Hormonal Effects of Danazol and Medical Oophorectomy in Endometriosis

  1983cited by this paper
• Inhibition of human granulosa cell progesterone secretion by a gonadotropin-releasing hormone agonist.

  1982cited by this paper
• Danazol has progestin-like actions on the human endometrium.

  1982cited by this paper
• Danazol: endocrine pharmacology and therapeutic applications.

  1981cited by this paper
• Sex Steroid Levels During Treatment of Endometriosis

  1979cited by this paper
• The absorption, distribution and metabolic fate of danazol in rats, monkeys and human volunteers.

  1976cited by this paper
• In vitro cultivation of human endometrium and the influences of steroid hormones on a cell line derived from the endometrium.

  1968cited by this paper

• A Novel Experimental Model of Colorectal Endometriosis

  2018cites this paper
• Paradigm Shift: The Realization of New Medical Alternatives to Surgery for Endometriosis

  2016cites this paper
• Kuntai Capsule Inhibited Endometriosis via Inducing Apoptosis in a Rat Model

  2016cites this paper
• Effect of SKI2670, a novel, orally active, non-peptide GnRH antagonist, on hypothalamic-pituitary-gonadal axis.

  2015cites this paper
• An overview of the current status of clinical trials on endometriosis: issues and concerns.

  2014cites this paper
• Treatment of endometriosis with local acetylsalicylic acid injection: experimental study in rabbits.

  2011cites this paper
• Long-term effects of GnRH agonist, GnRH antagonist, and estrogen plus progesterone treatment on apoptosis related genes in rat ovary.

  2009cites this paper
• Does Gestrinone Antagonize the Effects of Estrogen on Endometrial Implants Upon the Peritoneum of Rats?

  2008cites this paper
• Local application of danazol-loaded hyaluronic acid hydrogel to endometriosis in a rat model.

  2006cites this paper
• Animal models in endometriosis research.

  2006cites this paper
• Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib.

  2004cites this paper
• Modelo experimental para endometriose em coelhas com seguimento evolutivo das lesões

  2004cites this paper
• Development of an experimental model of endometriosis in rabbits

  2004cites this paper
• Effects of the Novel Orally Active Antiestrogen TZE-5323 on Experimental Endometriosis

  2003cites this paper
• Medical management of endometriosis-associated pain.

  2003cites this paper
• Was Sampson wrong?

  2002cites this paper
• Ability of recombinant human TNF binding protein-1 (r-hTBP-1) to inhibit the development of experimentally-induced endometriosis in rats.

  2000cites this paper
• A computer based, temperature controlled bipolar electrocoagulation system.

  1999cites this paper
• Computer based, temperature controlled bipolar electrocoagulation system. III. Effect on pregnancy rate in the rat.

  1999cites this paper
• Effects of dienogest, a synthetic steroid, on experimental endometriosis in rats.

  1998cites this paper
• Animal model of uterine adenomyosis: induction of the lesion in rats by ectopic pituitary isografting.

  1998cites this paper
• Inhibitory effects of a novel aromatase inhibitor, YM511, on growth of endometrial explants and insulin-like growth factor-I gene expression in rats with experimental endometriosis.

  1997cites this paper
• Individual and combined effects of triptoreline and gestrinone on experimental endometriosis in rats.

  1996cites this paper
• Combined use of a long-acting gonadotropin-releasing hormone agonist and low-dose danazol in advanced stage endometriosis.

  1996cites this paper
• Effect of gonadotropin-releasing hormone agonists, nafarelin, buserelin, and leuprolide, on experimentally induced endometriosis in the rat.

  1995cites this paper
• Electrocauterization in rats of experimentally induced endometriosis at a low temperature.

  1995cites this paper
• Fluorescence of experimental endometriosis in rabbits, using tamoxifen-eosin association.

  1995cites this paper
• Successful Heterotransplantation of Human Endometrium in SCID Mice

  1994cites this paper
• The hypothalamic‐pituitary‐ovarian axis in patients with endometriosis is suppressed by leuprolide acetate but not by danazol

  1994cites this paper
• Study of experimental endometriosis using fluorescence of eosin-tamoxifen association

  1993cites this paper
• Endometriosis: the present and the future—an overview of treatment options

  1992cites this paper